Benzinga | Nov 25, 2020 09:51AM EST

Oppenheimer Initiates Coverage On Teva Pharmaceutical Indus with Perform Rating

Oppenheimer analyst Leland Gershell initiates coverage on Teva Pharmaceutical Indus (NYSE:TEVA) with a Perform rating.